fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Longer treatment for male UTI not associated with reduced early or late recurrence risk

Written by | 21 Jan 2013

A study of more than 33,000 outpatient male veterans suggests that a longer duration of antimicrobial treatment of more than seven days for a urinary tract infection (UTI)… read more.

World’s largest respiratory genetics study launches on World COPD Day

Written by | 21 Dec 2012

Researchers from the Universities of Nottingham and Leicester are leading the largest ever study of the genetics relating to lung disease.

Children born after infertility treatment are more likely to suffer from asthma

Written by | 21 Dec 2012

Asthma is more common among children born after infertility treatment than among children who have been planned and conceived naturally, according to findings from the UK Millennium Cohort… read more.

Testing pain killers on humans could save money and speed the arrival of new drugs

Written by | 21 Dec 2012

Deliberately inflicting carefully controlled painful stimuli on human volunteers and seeing how well specific drugs reduce the feeling of pain can be an effective way of testing new… read more.

NSAIDs may protect liver

Written by | 21 Dec 2012

Nonsteroidal anti-inflammatory drugs, especially aspirin, may help prevent serious liver problems, a large observational study suggested.

NSAIDs may protect liver

Written by | 21 Dec 2012

Nonsteroidal anti-inflammatory drugs, especially aspirin, may help prevent serious liver problems, a large observational study suggested.

ASH 2012 Report – Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders

Written by | 21 Dec 2012

Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Haematology (ASH) signal an important step forward… read more.

ASH 2012 Report – New stem cell research, transplant strategies show promise to improve outcomes, reduce complications

Written by | 21 Dec 2012

Studies of stem cell biology and transplant approaches presented at the 54th Annual Meeting of the American Society of Haematology (ASH) illustrate how the use of advanced modelling… read more.

ASH 2012 Report – New drug cuts risk of transplant side effect in half

Written by | 21 Dec 2012

by Sung Choi, M.D., University of Michigan Comprehensive Cancer Center (pictured) First study in humans shows promise for preventing graft-versus-host disease following bone marrow transplant.

ASH 2012 Report – New multiple myeloma drug shows promise in treating people with advanced disease

Written by | 21 Dec 2012

Therapy may be new option for hard-to-treat blood cancer.

New drugs approved

Written by | 14 Dec 2012

by Gary Finnegan – EMA Highlights – The EMA has given its backing to a number of medicines including:

Gabapentin appears to offer relief of refractory chronic cough

Written by | 14 Dec 2012

by Bruce Sylvester – FDA Highlights – A study published online on August 27, 2012 in The Lancet suggests that gabapentin, a pain and seizure drug, significantly reduces… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.